341 related articles for article (PubMed ID: 18358099)
1. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
2. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay.
Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q
Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170
[TBL] [Abstract][Full Text] [Related]
4. Development of a complex scintillation proximity assay for high-throughput screening of PPARgamma modulators.
Wu B; Gao J; Wang MW
Acta Pharmacol Sin; 2005 Mar; 26(3):339-44. PubMed ID: 15715931
[TBL] [Abstract][Full Text] [Related]
5. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor.
Hui X; Gao J; Xie X; Suto N; Ogiku T; Wang MW
Acta Pharmacol Sin; 2005 Oct; 26(10):1175-80. PubMed ID: 16174432
[TBL] [Abstract][Full Text] [Related]
6. Development of a universal high-throughput calcium assay for G-protein- coupled receptors with promiscuous G-protein Galpha15/16.
Zhu T; Fang LY; Xie X
Acta Pharmacol Sin; 2008 Apr; 29(4):507-16. PubMed ID: 18358098
[TBL] [Abstract][Full Text] [Related]
7. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
Brighton PJ; Szekeres PG; Wise A; Willars GB
Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of novel antagonists on melanin-concentrating hormone receptor-1.
Yan JH; Li QY; Boutin JA; Renard MP; Ding YX; Hao XJ; Zhao WM; Wang MW
Acta Pharmacol Sin; 2008 Jun; 29(6):752-8. PubMed ID: 18501123
[TBL] [Abstract][Full Text] [Related]
9. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.
Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW
Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620
[TBL] [Abstract][Full Text] [Related]
10. Development of a homogeneous binding assay for histamine receptors.
Crane K; Shih DT
Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569
[TBL] [Abstract][Full Text] [Related]
11. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
[TBL] [Abstract][Full Text] [Related]
12. Screening and isolation of a natural dopamine D1 receptor antagonist using cell-based assays.
Yu S; Park JS; Paredes V; Song MC; Baek NI; Lee SI; Lim JS; Cho NY; Yoon J; Baek K
J Biotechnol; 2010 Feb; 145(3):304-9. PubMed ID: 19963021
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.
Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R
J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404
[TBL] [Abstract][Full Text] [Related]
14. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
15. Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor.
Rodgers G; Hubert C; McKinzie J; Suter T; Statnick M; Emmerson P; Stancato L
Assay Drug Dev Technol; 2003 Oct; 1(5):627-36. PubMed ID: 15090235
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
17. Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
Joesch C; Guevarra E; Parel SP; Bergner A; Zbinden P; Konrad D; Albrecht H
J Biomol Screen; 2008 Mar; 13(3):218-28. PubMed ID: 18270364
[TBL] [Abstract][Full Text] [Related]
18. Heterologous expression of human Neuromedin U receptor 1 and its subsequent solubilization and purification.
Xia H; Liu L; Reinhart C; Michel H
Biochim Biophys Acta; 2008 Oct; 1778(10):2203-9. PubMed ID: 18598671
[TBL] [Abstract][Full Text] [Related]
19. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.
Khawaja XZ
Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135
[TBL] [Abstract][Full Text] [Related]
20. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
Berry J; Price-Jones M; Killian B
Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
